Clinical Trial Update: Immune Modulation Study in Patients With Metastatic Melanoma Treated With Anti-PD1 Monoclonal Antibodies [Phase 4]

View source ↗

Summary

Phase 4 trial update on anti-PD1 monoclonal antibodies for metastatic melanoma indicates the study has completed (status: COMPLETED). No efficacy results are pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Metastatic Melanoma | Phase 4 | Status: COMPLETED